IPO Listing on July 21: Anthem Biosciences Limited will make its debut on NSE (National Stock Exchange) and BSE (Bombay Stock Exchange) on Monday, July 21. Anthem Biosciences IPO allotment finalised last week. The three-day subscription for Anthem Biosciences IPO was opened on July 14 (Monday) and closed on July 16 (Wednesday). On the closing day of the bidding, the initial public offer of Anthem Biosciences Ltd subscribed 63.86 times.
Anthem Biosciences IPO Subscription
The initial share sale received bids for 2,81,44,34,740 shares against 4,40,70,682 shares on offer, according to NSE data. The portion for qualified institutional buyers (QIBs) fetched a whopping 182.65 times subscription. The non-institutional investors part got subscribed 42.35 times, and retail individual investors (RIIs) received a 5.64 times subscription.
Anthem Biosciences IPO Price Band
Anthem Biosciences IPO has fixed the price band at Rs 540 to Rs 570 per equity share.
Anthem Biosciences IPO Registrar
KFin Technologies Limited is the registrar of Anthem Biosciences IPO.
Anthem Biosciences IPO Face Value, Tick Size
The face value and tick size of Anthem Biosciences IPO is Rs 2 and Re 1, respectively.
Anthem Biosciences IPO Listing Date
Anthem Biosciences Limited’s shares are proposed to be listed on NSE, and BSE. The listing will likely take place on July 21.
Anthem Biosciences IPO Book Running Lead Managers
JM Financial Limited, Citigroup Global Markets India Private Limited, J.P. Morgan India Private Limited and Nomura Financial Advisory and Securities (India) Private Limited are the book running lead managers for the Anthem Biosciences IPO.
Story continues below this ad
Anthem Biosciences IPO Sponsor Bank
HDFC Bank Limited and ICICI Bank Limited are the sponsor banks for the Anthem Biosciences IPO.
About Anthem Biosciences Limited
Anthem is into innovation-driven and technology-focused Contract Research, Development and Manufacturing Organization (CRDMO) with fully integrated operations spanning across drug discovery, development and manufacturing. It also manufactures and sells complex, specialised fermentation-based Active Pharmaceutical Ingredients (APIs), including probiotics, enzymes, peptides, nutritional actives, vitamin analogues and biosimilars.
(With inputs from PTI)
© IE Online Media Services Pvt Ltd
.